MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report

被引：0
|
作者：
Safi Alqatari
Peter Riddell
Sinead Harney
Michael Henry
Grainne Murphy
机构：
[1] Rheumatology Department,Royal College of Physicians of Ireland
[2] Cork University Hospital,Rheumatology Department
[3] Cork University Hospital,Internal Medicine and Rheumatology Consultant Rheumatology Department
[4] Cork University Hospital,undefined
来源：
BMC Pulmonary Medicine | / 18卷
关键词：
Myositis; Interstitial lung disease; MDA-5;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] A Case of Anti-MDA5 Antibody Polymyositis with Rapidly Progressive Interstitial Lung Disease
    MacDonald, D.
    Syed, M. K. Hayat
    Ingbar, D. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [12] Case of anti-MDA-5 positive dermatomyositis with rapidly progressive interstitial lung disease
    Fenando, Ardy
    Firn, Kim
    Louissa, Stefanie
    Hussain, Ammarah
    BMJ CASE REPORTS, 2020, 13 (04)
  • [13] Roles of biomarkers in anti-MDA5-positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
    Li, Xiaomeng
    Liu, Yongmei
    Cheng, Linlin
    Huang, Yuan
    Yan, Songxin
    Li, Haolong
    Zhan, Haoting
    Li, Yongzhe
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (11)
  • [14] Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease
    Tavakolian, Kameron
    Odak, Mihir
    Mararenko, Anton
    Ilagan, Justin
    Douedi, Steven
    Khan, Taimoor
    Al Saoudi, Ghadier
    JOURNAL OF MEDICAL CASES, 2022, 13 (08) : 374 - 379
  • [15] REMISSION FOLLOWING CRITICAL RESPIRATORY FAILURE DUE TO RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE ASSOCIATED WITH ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED GENE-5 (MDA-5)
    Dillon, Oliver
    Bastiampillai, Shalini A.
    CHEST, 2023, 164 (04) : 3229A - 3230A
  • [16] Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease
    A. Selva-O’Callaghan
    F. Romero-Bueno
    E. Trallero-Araguás
    A. Gil-Vila
    J. C. Ruiz-Rodríguez
    O. Sánchez-Pernaute
    I. Pinal-Fernández
    Current Treatment Options in Rheumatology, 2021, 7 : 319 - 333
  • [17] Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease
    Selva-O'Callaghan, A.
    Romero-Bueno, F.
    Trallero-Araguas, E.
    Gil-Vila, A.
    Ruiz-Rodriguez, J. C.
    Sanchez-Pernaute, O.
    Pinal-Fernandez, I.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2021, 7 (04) : 319 - 333
  • [18] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN ASSOCIATION WITH MDA5 ANTIBODY DERMATOMYOSITIS
    Kazmierski, Dan
    Sharma, Nishant
    Wang, Yichen
    Noumi, Bassel
    Ochieng, Pius
    Ejaz, Komal
    CHEST, 2020, 158 (04) : 1140A - 1141A
  • [19] Plasma exchange are not associated with better outcome in MDA5 Rapidly-Progressive Interstitial Lung disease
    Bay, P.
    De Chambrun, M. Pineton
    Vicent, R.
    Mahevas, M.
    De Prost, N.
    Roux, A.
    Zuber, B.
    Israel-Biet, D.
    Tazi, A.
    Baptiste, H.
    Luc, M.
    Mekinian, A.
    Deligny, C.
    Borie, R.
    Meurice, J. C.
    Meyer, A.
    Priou, P.
    Savale, L.
    Martin, L. De Saint
    Brillet, P. Y.
    Khafagy, P.
    Benveniste, O.
    Nunes, H.
    Allenbach, Y.
    Uzunhan, Y.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [20] PJP as the Index Presentation for Anti-MDA5+Dermatomyositis with Associated Rapidly Progressive Interstitial Lung Disease
    Onofrey, L.
    Harper, A.
    Chung, S.
    Disharoon, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
12345